Linden Thomas Advisory Services, LLC Halozyme Therapeutics, Inc. Transaction History
Linden Thomas Advisory Services, LLC
- $732 Billion
- Q3 2024
A detailed history of Linden Thomas Advisory Services, LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Linden Thomas Advisory Services, LLC holds 35,340 shares of HALO stock, worth $2.02 Million. This represents 0.28% of its overall portfolio holdings.
Number of Shares
35,340
Previous 35,328
0.03%
Holding current value
$2.02 Million
Previous $1.85 Billion
9.36%
% of portfolio
0.28%
Previous 0.29%
Shares
8 transactions
Others Institutions Holding HALO
# of Institutions
512Shares Held
124MCall Options Held
208KPut Options Held
77.1K-
Black Rock Inc. New York, NY17.6MShares$1.01 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.9MShares$736 Million0.01% of portfolio
-
State Street Corp Boston, MA5.81MShares$332 Million0.01% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.04MShares$231 Million4.92% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.72MShares$212 Million0.31% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $7.96B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...